These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 22118820)
21. Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique--a tool for controlled transdermal delivery of ibuprofen. Abioye AO; Issah S; Kola-Mustapha AT Int J Pharm; 2015 Jul; 490(1-2):112-30. PubMed ID: 25997660 [TBL] [Abstract][Full Text] [Related]
22. Nanoemulgel, an Innovative Carrier for Diflunisal Topical Delivery with Profound Anti-Inflammatory Effect: in vitro and in vivo Evaluation. Bashir M; Ahmad J; Asif M; Khan SU; Irfan M; Y Ibrahim A; Asghar S; Khan IU; Iqbal MS; Haseeb A; Khalid SH; As Abourehab M Int J Nanomedicine; 2021; 16():1457-1472. PubMed ID: 33654396 [TBL] [Abstract][Full Text] [Related]
23. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles. Sun L; Liu Z; Lin Z; Cun D; Tong HH; Yan R; Wang R; Zheng Y Int J Nanomedicine; 2018; 13():5625-5635. PubMed ID: 30271151 [TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evaluation of topical formulations of spantide II. Kikwai L; Babu RJ; Prado R; Kolot A; Armstrong CA; Ansel JC; Singh M AAPS PharmSciTech; 2005 Oct; 6(4):E565-72. PubMed ID: 16408858 [TBL] [Abstract][Full Text] [Related]
25. Breaking the Barrier - Potent Anti-Inflammatory Activity following Efficient Topical Delivery of Etanercept using Thermoresponsive Nanogels. Giulbudagian M; Yealland G; Hönzke S; Edlich A; Geisendörfer B; Kleuser B; Hedtrich S; Calderón M Theranostics; 2018; 8(2):450-463. PubMed ID: 29290820 [TBL] [Abstract][Full Text] [Related]
26. Delivery and Anti-Psoriatic Effect of Silibinin-Loaded Polymeric Micelles: An Experimental Study in the Psoriatic Skin Model. Chavoshy F; Zadeh BSM; Tamaddon AM; Anbardar MH Curr Drug Deliv; 2020; 17(9):787-798. PubMed ID: 32703129 [TBL] [Abstract][Full Text] [Related]
27. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Sathe P; Saka R; Kommineni N; Raza K; Khan W Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674 [TBL] [Abstract][Full Text] [Related]
28. Effects of nanoparticles with hydrotropic nicotinamide on tacrolimus: permeability through psoriatic skin and antipsoriatic and antiproliferative activities. Wan T; Pan W; Long Y; Yu K; Liu S; Ruan W; Pan J; Qin M; Wu C; Xu Y Int J Nanomedicine; 2017; 12():1485-1497. PubMed ID: 28260894 [TBL] [Abstract][Full Text] [Related]
29. Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs. Lin YK; Yang SH; Chen CC; Kao HC; Fang JY PLoS One; 2015; 10(9):e0137890. PubMed ID: 26355594 [TBL] [Abstract][Full Text] [Related]
30. Design & development of nanosponge loaded topical gel of curcumin and caffeine mixture for augmented treatment of psoriasis. Iriventi P; Gupta NV; Osmani RAM; Balamuralidhara V Daru; 2020 Dec; 28(2):489-506. PubMed ID: 32472531 [TBL] [Abstract][Full Text] [Related]
31. Development of a hydrogel containing bisabolol-loaded nanocapsules for the treatment of atopic dermatitis in a Balb/c mice model. Karami H; Niavand MR; Haddadi R; Noriyan A; Vafaei SY Int J Pharm; 2024 May; 656():124029. PubMed ID: 38527566 [TBL] [Abstract][Full Text] [Related]
32. Anti-psoriatic and toxicity evaluation of methotrexate loaded chitin nanogel in imiquimod induced mice model. Panonnummal R; Sabitha M Int J Biol Macromol; 2018 Apr; 110():245-258. PubMed ID: 29054520 [TBL] [Abstract][Full Text] [Related]
34. Development, optimization, and characterization of a novel tea tree oil nanogel using response surface methodology. Sinha P; Srivastava S; Mishra N; Singh DK; Luqman S; Chanda D; Yadav NP Drug Dev Ind Pharm; 2016 Sep; 42(9):1434-45. PubMed ID: 26821208 [TBL] [Abstract][Full Text] [Related]
35. Self-assembled mPEG-hexPLA polymeric nanocarriers for the targeted cutaneous delivery of imiquimod. Lapteva M; Mignot M; Mondon K; Möller M; Gurny R; Kalia YN Eur J Pharm Biopharm; 2019 Sep; 142():553-562. PubMed ID: 30641138 [TBL] [Abstract][Full Text] [Related]
36. Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay. Alalaiwe A; Lin CF; Hsiao CY; Chen EL; Lin CY; Lien WC; Fang JY Int J Pharm; 2020 May; 581():119256. PubMed ID: 32220586 [TBL] [Abstract][Full Text] [Related]
37. Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II. Babu RJ; Kikwai L; Jaiani LT; Kanikkannan N; Armstrong CA; Ansel JC; Singh M Pharm Res; 2004 Jan; 21(1):108-13. PubMed ID: 14984264 [TBL] [Abstract][Full Text] [Related]
38. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308 [TBL] [Abstract][Full Text] [Related]
39. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies. Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659 [TBL] [Abstract][Full Text] [Related]
40. Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity. Meng S; Sun L; Wang L; Lin Z; Liu Z; Xi L; Wang Z; Zheng Y Colloids Surf B Biointerfaces; 2019 Oct; 182():110352. PubMed ID: 31306831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]